BD is putting a fresh spin on an old awareness drive, returning to the 12-year-old “Love Your Limbs” campaign to mark Peripheral Artery Disease (PAD) Awareness Month. The company, which sells PAD ...
FRANKLIN LAKES, N.J., Feb. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next ...
FRANKLIN LAKES, N.J., Sept. 2, 2025 /PRNewswire/ -- In recognition of Peripheral Artery Disease (PAD) Awareness Month, BD (Becton, Dickinson and Company) (NYSE: BDX) is shining a spotlight on a ...
PHOENIX — A technology campus in Tempe has its first tenant — even though it is not expected to open for two more years. BD Peripheral Intervention — which develops and manufactures endovascular ...
FRANKLIN LAKES, N.J., May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today announced plans to initiate a patient data registry for ...
First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PAD FRANKLIN LAKES, N.J., March 4, 2024 /PRNewswire/ -- BD ...
Please provide your email address to receive an email when new articles are posted on . From 2006 to 2016, the percentage of patients presenting with critical limb ischemia, rates of femoral-popliteal ...
"The CE Marking of the Revello™ Stent is a significant advancement towards helping physicians treating complex iliac artery disease," said Rima Alameddine, worldwide president, BD Interventional – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results